MetaTOC stay on top of your field, easily

Anifrolumab induces a fast improvement in ultrasound-detected synovitis in systemic lupus erythematosus: Results from a 6-months follow-up ultrasound study

, , , , , , , , , , , ,

Lupus: An International Journal

Published online on

Abstract

Lupus, Ahead of Print.
ObjectiveAnifrolumab (ANF) has been approved to treat extra-renal manifestations in Systemic Lupus Erythematosus (SLE) patients. Real-life data underline the excellent efficacy in skin involvement, but very little is known on other manifestations. We ...